Lokon Pharma’s immunostimulatory gene therapy, delivered in oncolytic adenoviruses, are poised to enter pivotal trials for cancer. Biovian Oy is manufacturing Lokon’s immunotherapeutics for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback